3.248 articles found

Challenges and Opportunities of Early Parkinson's Disease Biomarkers: α-Synuclein, Leucine-Rich Repeat Kinase 2 (LRRK2), DJ-1, and microRNAs.

Heineman A, Linck J, Eylon A, Parmar MS.

Cureus · 2025-09-02

DOI: 10.7759/cureus.91510PMID: 41050048

Integrating Blood Biomarkers and Marine Brown Algae-Derived Inhibitors in Parkinson’s Disease: A Multi-scale Approach from Interactomics to Quantum Mechanics

Roshni J, Mahema S, Ahmad SF, Al-Mazroua HA, Manjunath Kamath S, Ahmed SSSJ.

Mol Biotechnol · 2025-09-01

[Frontiers in Digital Technology for Remote Monitoring and Home Management in Parkinson's Disease].

Shiraishi M, Yamano Y.

Brain Nerve · 2025-09-01

DOI: 10.11477/mf.188160960770090975PMID: 40935374

Imaging microtubule dynamics: A new frontier in biomarker development for neurodegenerative diseases.

Damuka N, Lockhart SN, Solingapuram Sai KK.

Alzheimers Dement · 2025-09-01

DOI: 10.1002/alz.70670PMID: 40985270

Locally adapting digital health technologies to address the global challenge of Parkinson's disease.

Lizárraga KJ, Salazar IC, Zizzi C, Romero S, Arispe JC, Quico AV, Dye TD, Dorsey ER, Castaneda B.

Equity Neurosci · 2025-09-01

DOI: 10.1016/j.neuros.2025.100010PMID: 41262226

Digital Outcomes of Upper Limb Ataxia Capture Meaningful Longitudinal Change and Treatment Response.

Hermle D, Schubert R, Barallon P, Ilg W, Schüle R, Reilmann R, Synofzik M, Traschütz A.

Mov Disord · 2025-09-01

DOI: 10.1002/mds.70012PMID: 40888004

CSF Mitochondrial DNA: Biomarker of Body Composition and Energy Metabolism in Parkinson's Disease.

Mizutani Y, Nakai T, Maeda Y, Ohdake R, Higashi A, Maeda T, Nagao R, Shima S, Kawabata K, Ueda A, Ito M, Watanabe H.

Ann Clin Transl Neurol · 2025-09-01

DOI: 10.1002/acn3.70183PMID: 40891077

Identification and experimental validation of biomarkers related to mitochondrial and programmed cell death in obsessive-compulsive disorder.

Mao G, Cong W.

Sci Rep · 2025-08-30

DOI: 10.1038/s41598-025-17606-wPMID: 40885831

Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinson's disease.

Guo H, Shen X, Lyu M, Zhou G, Chen C, Xing B, Xie Y.

Front Neurol · 2025-08-29

DOI: 10.3389/fneur.2025.1652378PMID: 40948659

Multimodal MRI biomarkers optimize differentiation between progressive supranuclear palsy and Parkinson's disease.

Chen T, Gong T, Chen Y, Yang A, Zhao C, Sun Z, Zhao Y, Zhou L, Chen W, Liu Y, Xiang Y, Wang G.

Neurobiol Dis · 2025-08-29

DOI: 10.1016/j.nbd.2025.107076PMID: 40886858

Digital speech assessments and machine learning for differentiation of neurodegenerative diseases.

Kang K, Nunes AS, Potter IY, Mishra RK, Geronimo A, Adams JL, Isroff C, Wang JE, Vaziri A, Wills AM, Pantelyat A.

Clin Park Relat Disord · 2025-08-28

DOI: 10.1016/j.prdoa.2025.100389PMID: 40933233

Serum LDH and NLR as Diagnostic Biomarkers for Drooling in Parkinson's Disease

Wang X, Shi J, Jin H, Gao Q, Huang Q, Wu L, Tian Y, Huang T, Zhang Y.

· 2025-08-27

DOI: 10.21203/rs.3.rs-7311117/v1